BL

Blair T. Lapointe

Merck: 6 patents #18 of 961Top 2%
LY Lycera: 2 patents #4 of 21Top 20%
📍 Brookline, MA: #20 of 501 inventorsTop 4%
🗺 Massachusetts: #497 of 14,267 inventorsTop 4%
Overall (2019): #26,844 of 560,194Top 5%
6
Patents 2019

Issued Patents 2019

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
10377768 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Kenneth J. Barr, Vladimir Simov, Karin Ann Stein, William D. Thomas +3 more 2019-08-13
10344000 Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof Peter H. Fuller, Hakan Gunaydin, Kun Liu, Danielle F. Molinari, Qinglin Pu +3 more 2019-07-09
10287272 Substituted indazole compounds as RORgammaT inhibitors and uses thereof Peter H. Fuller, Hakan Gunaydin, Kun Liu, Mark E. Scott, B. Wesley Trotter +1 more 2019-05-14
10221142 Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof Peter H. Fuller, Hakan Gunaydin, Kun Liu, Nunzio Sciammetta, Benjamin Wesley Trotter +5 more 2019-03-05
10221146 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2019-03-05
10196354 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, Corey E. Bienstock, John MacLean, Hongjun Zhang, Richard Thomas Beresis +3 more 2019-02-05